VRS
SRNE

Virginia Retirement Systems’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Virginia Retirement Systems’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,200
Closed -$93K – 1163
2021
Q1 		$93K Sell
11,200
-6,100
-35% -$64.4K ﹤0.01% 1091
2020
Q4 		$118K Sell
17,300
-30,700
-64% -$247K ﹤0.01% 1081
2020
Q3 		$535K Buy
+48,000
New +$439K 0.01% 740

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Virginia Retirement Systems's SRNE Position: Q2 2021 in Review

Virginia Retirement Systems sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2021, closing a stake of 11,200 shares — an estimated $93K sold.

Virginia Retirement Systems first reported a position in SRNE in Q3 2020 and held it in 3 quarters. The position peaked at $535K in Q3 2020. 212 funds tracked by Wall St. Rank hold SRNE as of Q2 2021.

  • Virginia Retirement Systems reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Virginia Retirement Systems sold 11,200 Sorrento Therapeutics, Inc. shares in Q2 2021, an estimated $93K.
  • Virginia Retirement Systems first reported a position in Sorrento Therapeutics, Inc. in Q3 2020 and held it in 3 quarters.
  • Virginia Retirement Systems's Sorrento Therapeutics, Inc. position peaked at $535K in Q3 2020.
  • 212 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2021.

Based on Virginia Retirement Systems's 13F filing for Q2 2021, filed 13 Aug 2021.